I'm an acupuncturist and herbalist practicing in Downtown Redding.
There is a modified herbal formula, Jing Fei Tang (Qing Fei Pai Du Tang), available to treat mild and severe covid-19 symptoms that I would like to make widely available as it can be 90% effective at keeping people out of hospitals and 50% effective at saving lives once hospitalized (resource links below).
There is currently an FDA approved double blind placebo trial being conducted in LA on this formula and it's been used in hospitals throughout China since January 2020.
Jing Fei Tang is available in powder extract tea ($47/bottle) or capsule ($16/bottle) form. The granule tea contains 100 grams and comes with a gram spoon to measure. Adults usually take between 4-6 grams/day (lasts 16-25 days) split into morning and evening doses and can take more if symptoms are severe. The capsules contains 100 caps that are about .5 grams each so equivalent would be 8-12 capsules (lasts 8-12 days) and best to take with warm water.
For kids adjust according to weight down from average adult weight.
All of the herbs in the formula have been used for thousands of years and are known to be safe. However, they may interact with medications like diuretics.
Contact Rhiannon at 530-276-8406 with quantity and type so I can get a good idea how much to pre-order. When they are available they will be at my office for pick up Fridays.
This information is not intended to replace the advice and care of a medical practitioner and I do not accept any responsibility for any consequences that may occur from consuming this phytomedicine.
Early use: over 60% significant improvement of covid symptoms, 30% stabilizing not worsening of symptoms
50% reduction in deaths from hospitalized individuals
WHO"...plays a role in balancing immunity and eliminating inflammation. It may act as an antiviral agent by targeting ribosomal proteins that are necessary for viral replication to inhibit viral mRNA translation and inhibiting a group of proteins that interact with viral proteins."
Open FDA approved clinical trial ending Dec 21